Tenders/ACTIVE SUBSTANCE EMICIZUMAB with successive deliveries to Hemophilia Treatment Centers
Awarded🇵🇱PolandSupplies

ACTIVE SUBSTANCE EMICIZUMAB with successive deliveries to Hemophilia Treatment Centers

Auto-translated from Polish
Original title: SUBSTANCJA CZYNNA EMICIZUMAB wraz z sukcesywnymi dostawami do Centrów Leczenia Hemofilii
Instytut Matki i Dziecka
Published: Oct 9, 2026
Updated: Oct 12, 2026
Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to Roche Polska Sp. z o.o. — €279,152,782

Browse open Health & Medical tenders in Poland

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Polish
1. The subject of the order includes successive deliveries in the years 2026-2028 of the active substance EMICIZUMAB with administration kits to ensure the continuity of treatment for patients with Factor VIII deficiency - hereinafter referred to as the "medicinal product", within the framework of the National Health Fund's therapeutic program "Prevention of bleeding in children with hemophilia A and B" - hereinafter referred to as the "NFZ program", as well as the organization of home deliveries to patients, understood as the patient's place of residence or permanent stay, for the indicated number of patients, delivery of containers for collecting used disposable equipment, collection and disposal of single-use equipment, and monitoring of drug consumption and education on the correct implementation of the aforementioned therapeutic program, on the terms specified in the SWZ. 2. The offered subject of the order must have a valid decision, i.e., be covered by reimbursement as of May 1, 2026. 3. Total quantity (basic purchase volume for 2026-2028): 961,368 mg. 4. Expiry date of the medicinal product and contents of the administration kit - in accordance with the SWZ. 5. Delivery volume and proportions of administration kit packaging: to be agreed with the Hemophilia Treatment Center. 6. Pursuant to Art. 256 of the Public Procurement Law. The Contracting Authority may annul the procurement procedure before the expiry of the deadline for submitting offers if circumstances arise that make further proceedings unjustified. 7. Pursuant to Art. 257 of the Public Procurement Law. The Contracting Authority may annul the procurement procedure if the public funds that the Contracting Authority intended to use to finance all or part of the order have not been granted to it. 8. The order must be executed in accordance with the requirements specified in the SWZ and the Draft Contract Provisions.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 9, 2026. Last refreshed 37 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Instytut Matki i Dziecka

Instytut Matki i Dziecka has issued 119 procurement notices on BidsFactory, including 3 currently open and 43 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU), Poland e-Zamówienia, and Baza Konkurencyjności. Most recent publication: November 17, 2026.

Instytut Matki i Dziecka: buyer profile, tenders and awards

Frequently asked questions about this tender

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Roche Polska Sp. z o.o.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Instytut Matki i Dziecka in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

Roche Polska Sp. z o.o. was awarded the contract for €279,152,782. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories